Péter Kósa

2.7k total citations
58 papers, 1.9k citations indexed

About

Péter Kósa is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Neurology. According to data from OpenAlex, Péter Kósa has authored 58 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pathology and Forensic Medicine, 20 papers in Molecular Biology and 9 papers in Neurology. Recurrent topics in Péter Kósa's work include Multiple Sclerosis Research Studies (26 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Fungal and yeast genetics research (5 papers). Péter Kósa is often cited by papers focused on Multiple Sclerosis Research Studies (26 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Fungal and yeast genetics research (5 papers). Péter Kósa collaborates with scholars based in United States, Slovakia and France. Péter Kósa's co-authors include Bibiana Bielekova, Thomas Bugge, Roman Szabo, Tianxia Wu, Mika Komori, Karin List, Laurent Kuras, Kevin Struhl, Mario Mencı́a and Alfredo Molinolo and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Péter Kósa

55 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Péter Kósa United States	26	832	541	242	236	221	58	1.9k
Sophie Chabot France	26	684 0.8×	310 0.6×	190 0.8×	925 3.9×	121 0.5×	54	2.3k
Kevin D. Pavelko United States	23	437 0.5×	447 0.8×	358 1.5×	770 3.3×	107 0.5×	71	2.0k
Yu-Min Huang Sweden	27	517 0.6×	557 1.0×	167 0.7×	1.2k 5.0×	125 0.6×	80	2.5k
Subramaniam Sriram United States	30	637 0.8×	529 1.0×	219 0.9×	1.0k 4.4×	74 0.3×	66	2.5k
Paul T. Massa United States	27	824 1.0×	263 0.5×	225 0.9×	1.2k 5.3×	175 0.8×	63	2.4k
Yan Fan United States	21	841 1.0×	221 0.4×	135 0.6×	316 1.3×	110 0.5×	37	1.5k
Yohei Kawano Japan	28	559 0.7×	646 1.2×	132 0.5×	1.5k 6.3×	142 0.6×	70	3.0k
Stephen D. Schibeci Australia	24	360 0.4×	268 0.5×	170 0.7×	569 2.4×	87 0.4×	44	1.3k
Sarah Shapiro Israel	17	334 0.4×	292 0.5×	162 0.7×	332 1.4×	47 0.2×	34	1.3k

Countries citing papers authored by Péter Kósa

Since Specialization

Citations

This map shows the geographic impact of Péter Kósa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Péter Kósa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Péter Kósa more than expected).

Fields of papers citing papers by Péter Kósa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Péter Kósa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Péter Kósa. The network helps show where Péter Kósa may publish in the future.

Co-authorship network of co-authors of Péter Kósa

This figure shows the co-authorship network connecting the top 25 collaborators of Péter Kósa. A scholar is included among the top collaborators of Péter Kósa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Péter Kósa. Péter Kósa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kósa, Péter, et al.. (2025). Smartphone postural sway and pronator drift tests as measures of neurological disability. BMC Neurology. 25(1). 50–50.

Kósa, Péter, Mika Komori, Rikke Ratzer, et al.. (2025). Profiling the Cerebrospinal Fluid Proteome in Progressive Multiple Sclerosis: Treatment Effects and Associations with IgM Oligoclonal Bands. Journal of Neuroimmune Pharmacology. 20(1). 98–98.

Kocot, Joanna, Péter Kósa, Shinji Ashida, et al.. (2025). Clemastine fumarate accelerates accumulation of disability in progressive multiple sclerosis by enhancing pyroptosis. Journal of Clinical Investigation. 135(10). 4 indexed citations

Kósa, Péter, et al.. (2022). Molecular models of multiple sclerosis severity identify heterogeneity of pathogenic mechanisms. Nature Communications. 13(1). 7670–7670. 13 indexed citations

Kósa, Péter, et al.. (2022). Enhancing the clinical value of serum neurofilament light chain measurement. JCI Insight. 7(15). 9 indexed citations

Pham, Linh, et al.. (2021). Smartphone-based symbol-digit modalities test reliably captures brain damage in multiple sclerosis. npj Digital Medicine. 4(1). 36–36. 35 indexed citations

Kósa, Péter, Tianxia Wu, Jonathan A. Phillips, et al.. (2020). Idebenone does not inhibit disability progression in primary progressive MS. Multiple Sclerosis and Related Disorders. 45. 102434–102434. 26 indexed citations

Walter, Peter J., Hongyi Cai, Mary Walter, et al.. (2020). Stevia Metabolites in Biosamples Ranging from Fetal Life to Adulthood. Current Developments in Nutrition. 4. nzaa055_011–nzaa055_011. 2 indexed citations

Castro, Kamilah, Achilles Ntranos, Maria Petracca, et al.. (2019). Body Mass Index in Multiple Sclerosis modulates ceramide-induced DNA methylation and disease course. EBioMedicine. 43. 392–410. 41 indexed citations

10.

Weideman, Ann Marie, et al.. (2019). Smartphone Level Test Measures Disability in Several Neurological Domains for Patients With Multiple Sclerosis. Frontiers in Neurology. 10. 358–358. 19 indexed citations

11.

Masvekar, Ruturaj, et al.. (2018). Cerebrospinal fluid biomarkers link toxic astrogliosis and microglial activation to multiple sclerosis severity. Multiple Sclerosis and Related Disorders. 28. 34–43. 34 indexed citations

12.

Xu, Quangang, Elena Romm, Simone C. Wuest, et al.. (2018). Intrathecal B Cells in MS Have Significantly Greater Lymphangiogenic Potential Compared to B Cells Derived From Non-MS Subjects. Frontiers in Neurology. 9. 554–554. 9 indexed citations

13.

Kósa, Péter, Mika Komori, Makoto Tanigawa, et al.. (2017). Molecular-based diagnosis of Multiple Sclerosis and its progressive stage. The Journal of Immunology. 198(Supplement_1). 55.23–55.23. 1 indexed citations

14.

Kósa, Péter, Mika Komori, Tianxia Wu, et al.. (2015). Novel composite MRI scale correlates highly with disability in multiple sclerosis patients. Multiple Sclerosis and Related Disorders. 4(6). 526–535. 19 indexed citations

15.

Kósa, Péter, et al.. (2012). Additív gyártással készített testek alakhelyességének vizsgálata. 1. (2012). 99–102. 1 indexed citations

16.

Szabo, Roman, Péter Kósa, Johanna M. Schafer, et al.. (2011). c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase. Oncogene. 30(17). 2003–2016. 74 indexed citations

17.

List, Karin, Péter Kósa, Roman Szabo, et al.. (2009). Epithelial Integrity Is Maintained by a Matriptase-Dependent Proteolytic Pathway. American Journal Of Pathology. 175(4). 1453–1463. 109 indexed citations

18.

Szabo, Roman, et al.. (2009). Regulation of cell surface protease matriptase by HAI2 is essential for placental development, neural tube closure and embryonic survival in mice. Development. 136(15). 2653–2663. 94 indexed citations

19.

Nosek, Jozef, Péter Kósa, & Ľubomír Tomáška. (2006). On the origin of telomeres: a glimpse at the pre-telomerase world. BioEssays. 28(2). 182–190. 45 indexed citations

20.

Tsai, Francis, Otis Littlefield, Péter Kósa, et al.. (1998). Polarity of Transcription on Pol II and Archaeal Promoters: Where Is the "One-way Sign" and How Is It Read?. Cold Spring Harbor Symposia on Quantitative Biology. 63(0). 53–62. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact